Forecast & Rating9 analysts currently cover ATYR Pharma, with about 44.4% giving a positive rating — meaning they expect the stock to rise. The average price target is $2.86, about 682.6% upside from the current price of $0.37. Price targets range from $1.00 to $7.00 — a wide spread, showing clear disagreement over just how much ATYR Pharma can rise. For you, this means institutional views on ATYR Pharma are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Aug 10, 2026; for reference only and not investment advice.
Aug 10, 2026Price forecast
$2.86682.56%
Forecast & RatingBuy
9analysts
- Strong buy22.22%
- Buy22.22%
- Hold55.56%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 21, 2026
Forecast met0.0%
Stock price$0.37
Avg. target$4.4
High target$20
Low target$1
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.